Surg Today 38:716725 Park J, Hwang S, Yoon I (2017) Advanced growth factor delivery systems in wound management and skin regeneration
De Graaf C, Donnelly D, Wootten D et al (2016) Glucagon-like peptide-1 and its class B G protein-coupled receptors: a long march to therapeutic successes
Salven P, Lymboussaki A, Heikkil P, Jskela-Saari H, Enholm B, Aase K, et al
2025 calorie balance study: Time-restricted eating showed no measurable improvements in metabolic or cardiovascular health when calorie intake remained unchanged
Ultimately, the risk of gallbladder events with GLP-1 medications should be weighed against their overall cardiometabolic benefits
Broad Application in Cardiovascular Concerns: Major Potential In 2025, crucial research activities will be developing new applications of GLP-1 receptor agonists in heart conditions, including protective effects on the heart and blood vessels, probably decreasing the risk of heart attack, stroke, and other cardiovascular events